Abstract
Sodium butyrate (NaB) induced the membrane enclosed cell size vesicles from several IgM producing cell lines. We considered the application of the cell-derived vesicles (CDVs) to drug delivery system (DDS) using the lung cancer specific IgM producing AE6 cell line. Microscopic observation showed that the DiI fluorescence labeled AE6 vesicles were incorporated into the lung cancer cell line A549. The anticancer drug, actinomycin D (actD), contained in AE6 and Ramos vesicles decreased the A549 cell viability to 46 and 62% of control without actD, respectively. The cytotoxic effect in AE6 vesicles was superior to that in the Ramos vesicles that have the lung cancer non-specific IgM on their surfaces. However, the result of the Ramos vesicles suggests that the surface molecules other than IgM may interact with the A549 cells. In our method for vesicle production, more specific and abundant antibodies mounted vesicles can be generated by transfection of their genes into cells followed by NaB treatment. These suggest that the CDVs may be useful for the development of a drug carrier for DDS.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Buttgereit P, Weineck S, Röpke G, Märten A, Brand K, Heinicke T, Caselmann WH, Huhn D, Schmidt-Wolf IG (2000) Efficient gene transfer into lymphoma cells using adenoviral vectors combined with lipofection. Cancer Gene Ther 7:1145–1155
Immordino ML, Dosio F, Cattel L (2006) Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomed 1:297–315
Inoue Y, Fujisawa M, Kawamoto S, Shoji M, Hashizume S, Fujii M, Katakura Y, Shirahata S (1999) Effectiveness of vitamin A acetate for enhancing the production of lung cancer specific monoclonal antibodies. Cytotechnology 31:77–83
Jiang Z, Sharfstein ST (2008) Sodium butyrate stimulates monoclonal antibody over-expression in CHO cells by improving gene accessibility. Biotechnol Bioeng 100:189–194
Kawahara H, Shirahata S, Tachibana H, Murakami H (1992) In vitro immunization of human lymphocytes with human lung cancer cell line A549. Hum Antibodies Hybridomas 3:8–13
Michel M, Winterhalter M, Darbois L, Hemmerie J, Voegel JC, Schaaf P, Ball V (2004) Giant liposome microreactors for controlled production of calcium phosphate crystals. Langmuir 20:6127–6133
Murakami H, Hashizume S, Ohashi H, Shinohara K, Yasumoto K, Nomoto K, Omura H (1985) Human-human hybridomas secreting antibodies specific to human lung carcinoma. In Vitro Cell Dev Biol 21:593–596
Noireaux V, Libchaber A et al (2004) A vesicle bioreactor as a step toward an artificial cell assembly. Proc Natl Acad Sci USA 101:17669–17674
Park JW, Benz CC, Martin FJ (2004) Future directions of liposome- and immunoliposome-based cancer therapeutics. Semin Oncol 31:196–205
Rigaud JL, Levy D (2003) Reconstitution of membrane proteins into liposomes. Method Enzymol 372:65–86
Schwartz B, Avivi-Green C, Polak-Charcon S (1998) Sodium butyrate induces retinoblastoma protein dephosphorylation, p16 expression and growth arrest of colon cancer cells. Mol Cell Biochem 188:21–30
Shoji M, Kawamoto S, Sato S, Kamei M, Kato M, Hashizume S, Seki K, Yasumoto K, Nagashima A, Nakahashi H, Suzuki T, Imai T, Nomoto K, Murakami H (1994) Specific reactivity of human antibody AE6F4 against cancer cells in tissues and sputa from lung cancer patients. Hum Antibodies Hybridoma 5:116–122
Tsukamoto Y, Nakamura S, Inoue A, Nishino N, Inoue Y, Kawahara H (2009) Development of protein high expression system by using fructose metabolism. In: Kamihira M et al. (eds) JAACT2008: power of cells. The 21st annual and international meeting of the Japanese association for animal cell technology, Fukuoka, November 2008. Animal Cell Technology: Basic & Applied Aspects, vol 16. Springer, Dordrecht, The Netherlands (in press)
Vidali G, Boffa LC, Bradbury EM, Allfrey VG (1978) Butyrate suppression of histone deacetylation leads to accumulation of multiacetylated forms of histones H3 and H4 and increased DNase I sensitivity of the associated DNA sequences. Proc Natl Acad Sci USA 75:2239–2243
Watanabe N, Dickinson DA, Krzywanski DM, Iles KE, Zhang H, Venglarik CJ, Forman HJ (2002) A549 subclones demonstrate heterogeneity in toxicological sensitivity and antioxidant profile. Am J Physiol Lung Cell Mol Physiol 283:L726–L736
Yamanaka M, Nakamura S, Inoue A, Yasuda T, Inoue Y, Kawahara H (2009) Characterization of cell-sized vesicles induced from human lymphoid cell lines. In: Kamihira M et al (eds) JAACT2008: power of cells. The 21st annual and international meeting of the Japanese association for animal cell technology, Fukuoka, November 2008. Animal Cell Technology: Basic & Applied Aspects, vol 16. Springer, Dordrecht, The Netherlands (in press)
Acknowledgments
We gratefully thank the kind provision of K562 cells by Dr. Mari Maeda Yamamoto, National Institute of Vegetable and Tea Science, National Agriculture and Food Research Organization, Shizuoka, Japan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yamanaka, M., Nakamura, S., Inoue, A. et al. Induction of cell size vesicles from human lymphoma cell lines and their application to drug carriers. Cytotechnology 62, 287–291 (2010). https://doi.org/10.1007/s10616-009-9248-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10616-009-9248-2